Viracta Therapeutics (VIRX) PT Raised to $36 at Oppenheimer, After Closing Merger With SNSS
Tweet Send to a Friend
Oppenheimer analyst Hartaj Singh raised ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
